28 October 2022

---

NovoDynamics granted patent for periodontitis, periodontal disease assessment technology

---

NovoDynamics, Inc. announced on Oct. 13 that the U.S. Patent Office issued a patent for the company’s Methods and Systems for Periodontal Disease Screening technology for evaluating dental radiographs, or x-rays, and associated documentation to assess periodontitis and periodontal disease.

According to a news release, this technology is part of the NovoDynamics NovoHealth Dental solution, supporting clinician and payer decisions with objective, statistically driven disease assessments. NovoHealth Dental has been shown to meet or exceed the performance of committees of periodontists examining the same evidence.

Filed in 2019, the patent describes methods and systems that were incorporated and developed in the NovoHealth Dental platform which automatically analyzes dental insurance claims in real time. The platform also delivers accurate clinical assessments, uncovers fraud, waste and abuse, and efficiently streamlines claim review to accelerate reimbursement.

The NovoHealth Dental Periodontitis Disease Assessment module can achieve high-quality results even when only low-quality or non-diagnostic quality radiograph images are available. It pinpoints affected sites, assesses severity and determines whether claimed procedures meet the patient dental insurance plan reimbursement criteria.

“Evaluating claims for periodontal services such as scaling and root planing, and even gum surgery, can be time consuming and particularly challenging,” said Dr. Joseph Borg, DDS, dental director at NovoDynamics in the release.

Learn more about the patent and NovoDynamics at: https://www.novohealthdental.com/